|
|
Post by prcgorman2 on Nov 1, 2023 23:09:44 GMT -5
It is hard to believe share price can be controlled through manipulation and insider trading *cough*, but it seems the market knew long before the folks here that 3Q results would be a moderate improvement over 2Q.
|
|
|
|
Post by longliner on Nov 1, 2023 23:14:34 GMT -5
Just watch brother. The fun has just begun!
|
|
|
|
Post by MnkdWASmyRtrmntPlan on Nov 2, 2023 7:06:06 GMT -5
I agree with MyMann. I think there will be a small run-up toward ER, but probably not higher than $4.50. I am guessing that SP will come back down to settle in the 4.00's to 4.10's, and not go back up emuch higher than $4.20 until Q4 ER. It looks like Q3 is a disappointment, but I think Q4 will pick up the slack from Q3. The run-up in Q4 should go over (possibly well-over) $5.00 and settle back down to the mid-to-high $4.xx range. And as usual, I totally agree with Cretin ... your last 2 points are solid.
PRC - exactly! I can't wait to hear Mike's explanation is for this Q3 disappointment.
Longliner - I hope your are right. Thanks for providing that breath of hope for the future (even if it's not until next year).
|
|
|
|
Post by peppy on Nov 2, 2023 9:32:33 GMT -5
MNKD Nasdaq real time volume at 1 hour of trade,....................... Huge 1 hour volume for MNKD. 685,493 shares. $3.90 3.35% -0.14 www.nasdaq.com/market-activity/stocks/mnkd/real-timewww.google.com/finance/quote/MNKD:NASDAQ?hl=enMNKD daily, schrts.co/YyFfdgkkadded, 1 and 1/2 hours of trade, $3.925 -0.105 (-2.61%) Volume: 999,902added, at 2 hours of trade, MNKD real time volume, $3.875 -0.155 (-3.85%) Volume: 1,315,5182 hours and 6 mins of trade,........ $3.85 -0.18 (-4.47%) Volume: 1,620,053.............. 300,000 shares in 6 mins. NOV 2, 2023 11:36 AM ET UTHR moving up $227.79 1.66% +3.71 .MNKD volume at 3 hours of trade, HUGE for MNKD. Volume: 1,923,956$3.94 -0.09 (-2.23%)
Perhaps our large seller is gone. |
|
|
|
Post by hellodolly on Nov 2, 2023 9:33:21 GMT -5
I agree with MyMann. I think there will be a small run-up toward ER, but probably not higher than $4.50. I am guessing that SP will come back down to settle in the 4.00's to 4.10's, and not go back up emuch higher than $4.20 until Q4 ER. It looks like Q3 is a disappointment, but I think Q4 will pick up the slack from Q3. The run-up in Q4 should go over (possibly well-over) $5.00 and settle back down to the mid-to-high $4.xx range. And as usual, I totally agree with Cretin ... your last 2 points are solid. PRC - exactly! I can't wait to hear Mike's explanation is for this Q3 disappointment. Longliner - I hope your are right. Thanks for providing that breath of hope for the future (even if it's not until next year). If not, next Fib retracement level from here around $3.51 |
|
|
|
Post by Chris-C on Nov 2, 2023 11:24:50 GMT -5
I agree with MyMann. I think there will be a small run-up toward ER, but probably not higher than $4.50. I am guessing that SP will come back down to settle in the 4.00's to 4.10's, and not go back up emuch higher than $4.20 until Q4 ER. It looks like Q3 is a disappointment, but I think Q4 will pick up the slack from Q3. The run-up in Q4 should go over (possibly well-over) $5.00 and settle back down to the mid-to-high $4.xx range. And as usual, I totally agree with Cretin ... your last 2 points are solid. PRC - exactly! I can't wait to hear Mike's explanation is for this Q3 disappointment. Longliner - I hope your are right. Thanks for providing that breath of hope for the future (even if it's not until next year). If not, next Fib retracement level from here around $3.51 So here’s a serious question in the face of the latest disappointment that MNKD and its manipulators have dished up that moves my hope of a decent ROI still further down the highway. I never thought I would consider this after sticking it out for over a decade. I’m not investing for my kids inheritance, so time matters, as I’m already retired. Given that UTHR seems to be both competently run and better liked by the market, am I better off “unloading” (in many ways) my MNKD position and buying UTHR? Target prices for Martine’s company are now around$300, or roughly a 30% increase in SP over the near term. Plus, we all know that forecasts for MNKD are seldom realized. The potential for a similar 30% increase in MNKD’s SP has been speculated here for the next 9 months too, but this company does NOT have a track record of meeting expectations (to put it as kindly as I can) and the glowing promise of Tyvaso is already turning out to be a mirage. They say the best predictor of future performance is past performance. I realize that investing in biotech is risky and everyone has their own list of factors to consider when owning an equity position, including time horizon. But I know there are others on this board who have endured the long term pain and frustration of owning this, and I wonder how many might be sharing the same foxhole of frustration and considering raising a white flag? Chris C |
|
|
|
Post by MnkdWASmyRtrmntPlan on Nov 2, 2023 11:29:32 GMT -5
I agree with MyMann. I think there will be a small run-up toward ER, but probably not higher than $4.50. I am guessing that SP will come back down to settle in the 4.00's to 4.10's, and not go back up emuch higher than $4.20 until Q4 ER. It looks like Q3 is a disappointment, but I think Q4 will pick up the slack from Q3. The run-up in Q4 should go over (possibly well-over) $5.00 and settle back down to the mid-to-high $4.xx range. And as usual, I totally agree with Cretin ... your last 2 points are solid. PRC - exactly! I can't wait to hear Mike's explanation is for this Q3 disappointment. Longliner - I hope your are right. Thanks for providing that breath of hope for the future (even if it's not until next year). If not, next Fib retracement level from here around $3.51 Fib retracement? Ha, you're out of my league, Hello. That sounds scientific. I was just talking gut-feel guesswork. Pretty much the opposite of science  But, I certainly don't like the sound of $3.51. Ouch! |
|
|
|
Post by MnkdWASmyRtrmntPlan on Nov 2, 2023 11:43:36 GMT -5
If not, next Fib retracement level from here around $3.51 So here’s a serious question in the face of the latest disappointment that MNKD and its manipulators have dished up that moves my hope of a decent ROI still further down the highway. I never thought I would consider this after sticking it out for over a decade. I’m not investing for my kids inheritance, so time matters, as I’m already retired. Given that UTHR seems to be both competently run and better liked by the market, am I better off “unloading” (in many ways) my MNKD position and buying UTHR? Target prices for Martine’s company are now around$300, or roughly a 30% increase in SP over the near term. Plus, we all know that forecasts for MNKD are seldom realized. The potential for a similar 30% increase in MNKD’s SP has been speculated here for the next 9 months too, but this company does NOT have a track record of meeting expectations (to put it as kindly as I can) and the glowing promise of Tyvaso is already turning out to be a mirage. They say the best predictor of future performance is past performance. I realize that investing in biotech is risky and everyone has their own list of factors to consider when owning an equity position, including time horizon. But I know there are others on this board who have endured the long term pain and frustration of owning this, and I wonder how many might be sharing the same foxhole of frustration and considering raising a white flag? Chris C Chris, I feel your pain. No, I SHARE your pain. I have been in since 2015 and there isn't a retirement advisor alive that wouldn't tell me I am nuts for keeping the percentage of my retirement funds in MNKD that I keep. I know, it's nuts. But, I am still holding on. Don't get me wrong. I'm not giving anyone advice. Just sharing my situation. I still think next year will change. Like it has been mentioned here today, tomorrow is always tomorrow. This will be the 7th year that I have been saying next year. |
|
|
|
Post by peppy on Nov 2, 2023 11:50:31 GMT -5
MNKD Nasdaq real time volume at 1 hour of trade,....................... Huge 1 hour volume for MNKD. 685,493 shares. $3.90 3.35% -0.14 www.nasdaq.com/market-activity/stocks/mnkd/real-timewww.google.com/finance/quote/MNKD:NASDAQ?hl=enMNKD daily, schrts.co/YyFfdgkkadded, 1 and 1/2 hours of trade, $3.925 -0.105 (-2.61%) Volume: 999,902added, at 2 hours of trade, MNKD real time volume, $3.875 -0.155 (-3.85%) Volume: 1,315,5182 hours and 6 mins of trade,........ $3.85 -0.18 (-4.47%) Volume: 1,620,053.............. 300,000 shares in 6 mins. NOV 2, 2023 11:36 AM ET UTHR moving up $227.79 1.66% +3.71 .MNKD volume at 3 hours of trade, HUGE for MNKD. Volume: 1,923,956$3.94 -0.09 (-2.23%)
Perhaps our large seller is gone. I missed the half by three mins. The seller looks finished for the day, would be nice. $3.98 -0.05 (-1.24%) Volume: 1,972,702 NOV 2, 2023 12:48 PM ET |
|
|
|
Post by peppy on Nov 2, 2023 12:26:15 GMT -5
A picture, back to $4.00
$4.00
0.87%
-0.035 Today
$4.00 -0.03 (-0.74%)
Volume: 2,109,807
NOV 2, 2023 1:25 PM ET
|
|
|
|
Post by hellodolly on Nov 2, 2023 12:32:42 GMT -5
If not, next Fib retracement level from here around $3.51 So here’s a serious question in the face of the latest disappointment that MNKD and its manipulators have dished up that moves my hope of a decent ROI still further down the highway. I never thought I would consider this after sticking it out for over a decade. I’m not investing for my kids inheritance, so time matters, as I’m already retired. Given that UTHR seems to be both competently run and better liked by the market, am I better off “unloading” (in many ways) my MNKD position and buying UTHR? Target prices for Martine’s company are now around$300, or roughly a 30% increase in SP over the near term. Plus, we all know that forecasts for MNKD are seldom realized. The potential for a similar 30% increase in MNKD’s SP has been speculated here for the next 9 months too, but this company does NOT have a track record of meeting expectations (to put it as kindly as I can) and the glowing promise of Tyvaso is already turning out to be a mirage. They say the best predictor of future performance is past performance. I realize that investing in biotech is risky and everyone has their own list of factors to consider when owning an equity position, including time horizon. But I know there are others on this board who have endured the long term pain and frustration of owning this, and I wonder how many might be sharing the same foxhole of frustration and considering raising a white flag? Chris C Chris, I completely understand. I'm guessing near the same age, retired (actually double dipping again) have a large core (probably not as large as most but, I don't ever bet the farm), retirement funding 100% secured, holdings with a low average at $2.05 in MNKD and momma let's me day trade on the side (she says I earned it). Outside my core position at $2.05, I trade the heck out of this stock...but, with the caveat that I accumulate a few thousand shares each quarter and sell them around each EC. I've been so damn lucky because it has put a great amount of profit back into my IRA every quarter. Sure, I've had a miss here and there but, more wins each quarter than losses. If it misses, I hold onto the shares and just wait for the next pop on good news or the next EC. As to buying UTHR, I have no position in it. MNKD has been too easy to take profits in my day trading account. I'm stretched out into many, many, many other equities, including BP, why not keep both? I hear you on your retirement goals. I'm actually the opposite and building a legacy portfolio. My wife and I aren't ever going to spend this. We took 40 years to save, so I can't turn on the switch and spend like a drunken sailor now. I guess bottom line is it all depends on your personal financial goals. Why not buy some UTHR? I don't see much downside and it looks like it's had a nice pull back. LQDA announcing any wins with their patent issues might give you a better entry price for the long term. Heck, I might even jump in myself. |
|
|
|
Post by MnkdWASmyRtrmntPlan on Nov 2, 2023 12:42:43 GMT -5
In the past 2 hours, MNKD went from $3.83 to 4.06 and still headed upward.
Did someone here cast a spell?
Edit: now, at 2:00 it's back to $4.00 ... another hope out the window.
|
|
|
|
Post by veritasfiliatemporis on Nov 2, 2023 12:50:46 GMT -5
Shorts playing before conf call..
|
|
|
|
Post by akemp3000 on Nov 2, 2023 12:51:35 GMT -5
IMO if it leaked that a poor 3Q report was coming, we should be seeing a higher volume of trading activity. There hasn't been significant volume topping 5M shares in over 45 days. The current price movement at commonly low or average volumes may not be reflective of anything more than trading games. Let's see what happens next week IF significant shares are traded in a day as this should more accurately reflect market opinion.
|
|
|
|
Post by JEvans on Nov 2, 2023 12:54:42 GMT -5
In the past 2 hours, MNKD went from $3.83 to 4.06 and still headed upward. Did someone here cast a spell? We've been on a roller coaster ride the last week and a 1/2. I can't wait for earnings call to see what what that brings....The skies the limit |
|
